A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis-Reference-Cited by-同舟云学术

A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis

Published:2018-01-30 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ribecco-Lutkiewicz Maria,Sodja Caroline,Haukenfrers Julie,Haqqani Arsalan S.,Ly Dao,Zachar Peter,Baumann Ewa,Ball Marguerite,Huang Jez,Rukhlova Marina,Martina Marzia,Liu Qing,Stanimirovic Danica,Jezierski Anna,Bani-Yaghoub Mahmud

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-19522-8.pdf

Reference68 articles.

1. Arrowsmith, J. & Miller, P. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov 12, 569 (2013).

2. Dawson, G. R., Dourish, C. T. & Goodwin, G. M. Special issue on CNS experimental medicine. J Psychopharmacol 25, 1145–1147 (2011).

3. Palmer, A. M. & Alavijeh, M. S. Translational CNS medicines research. Drug Discov Today 17, 1068–1078 (2012).

4. Gabathuler, R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 37, 48–57 (2010).

5. Neuwelt, E. A. et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12, 169–182 (2011).

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Blood-Brain Barrier Models for Neuroinfectious Diseases: A Narrative Review;Current Neuropharmacology;2024-07

2. Single-Step 3D Bioprinting of Alginate–Collagen Type I Hydrogel Fiber Rings to Promote Angiogenic Network Formation;Tissue Engineering Part C: Methods;2024-07-01

3. Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria;Frontiers in Drug Delivery;2024-03-12

4. Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22;Molecular Therapy: Oncology;2024-03

5. Host-microbe interactions at the blood-brain barrier through the lens of induced pluripotent stem cell-derived brain-like endothelial cells;mBio;2024-02-14